|
|
40
|
|
|
76712
|
|
|
ACTILYSE 50MG INJ (BOE/STO) ALTEPLASE
|
|
|
ALTEPLASE
|
|
|
ACTILYSE
|
|
|
2X50MG
|
|
|
BQ
|
|
|
4,817.93
|
|
|
2,408.97
|
|
|
50MG
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
BOE
|
|
|
BOEHRINGER INGELHEIM
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
201220
|
|
|
THROMBOLYTIC AGENTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|